Insider · CIK 0001219039
Keith Crandell
ownerdirector
Files at MASS (908 Devices Inc.), TWST (Twist Bioscience Corp), LYEL (Lyell Immunopharma, Inc.), NMRA (Neumora Therapeutics, Inc.), PRME (Prime Medicine, Inc.), MTSR (Metsera, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2025 | MASS 908 Devices Inc. | MOption exercise Common Stock | +11,364 | - | - | 25,291 | Jun 13, 2025 |
| Jun 11, 2025 | MASS 908 Devices Inc. | MOption exercise Restricted Stock Unitsderivative | -11,364 | $0.00 | $0 | 0 | Jun 13, 2025 |
| Jun 12, 2025 | MASS 908 Devices Inc. | AGrant or award Restricted Stock Unitsderivative | +14,083 | $0.00 | $0 | 14,083 | Jun 13, 2025 |
| Jun 12, 2025 | MASS 908 Devices Inc. | AGrant or award Stock Option (option to buy)derivative | +6,516 | $0.00 | $0 | 6,516 | Jun 13, 2025 |
| Feb 5, 2025 | TWST Twist Bioscience Corp | AGrant or award Common Stock | +4,472 | $0.00 | $0 | 22,476 | Feb 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.